UP: Yogi Adityanath Govt To Provide Free Remdesivir To Critically Ill COVID-19 Patients

by IANS - Apr 27, 2021 06:38 AM
UP: Yogi Adityanath Govt To Provide Free Remdesivir To Critically Ill COVID-19 PatientsUP CM Yogi Adityanath (representative image) (Pic Via Twitter)

In a major relief to the critically-ill Covid patients admitted at Uttar Pradesh government and private hospitals, Chief Minister Yogi Adityanath has ordered that they should be provided Remdesivir injections free of cost.

However, the private hospitals will have to procure this drug from the manufacturing companies and the market itself.

In case, Remdesivir is not available in private hospitals and it is essential for the survival of any patient, then on the basis of the prescription issued by the hospital, the district magistrate and the Chief Medical Officer (CMO) can provide this life-saving drug for the concerned patient.

Orders in this regard have been issued by the department of health and family welfare.

The chief minister has also ordered that adequate vials of Remdesivir should be made available to various districts as per the demand. If required, private hospitals should also be provided Remdesivir at fixed rates.

To curb the illegal sale of essential drugs amid the rising corona virus infections in the state, the chief minister has said that the National Security Act (NSA) should be invoked against people who are involved in black-marketing of Covid-19 medicines.

Yogi Adityanath also asked the officials to ensure that there is no wastage of vaccines.

Stating that the survival of the patient is the priority of the government, he said, "Do the testing before providing Remdesivir or other life-saving drugs to the patients, so that no negative reaction takes place in patient's body."

The government spokesman , meanwhile, said that Remdesivir will be supplied by Uttar Pradesh Medical Supplies Corporation Ltd at all the government and private hospitals and medical colleges.

Every day, one Remdesivir vial will be given to patients of non-invasive ventilation beds of private and government hospitals and medical colleges.

At present, around 5,500 patients are being given this injection on a daily basis. The distribution of this injection is being made through Director General, Medical Education and Training, and Uttar Pradesh Medical Supplies Corporation Limited.

Remdesivir will be only given to patients who are admitted at the hospital and on the basis of the doctor's prescription.

The state Medical Colleges will also make arrangements to ensure the availability of the Remdesivir to the patients. Remdesivir vials will be provided every day to hospitals having L-2 COVID beds.

Each district of Uttar Pradesh will be given 1,800 vials of Remdesivir for an emergency situation. These vials will be given to patients at the fixed rates so that the life of a person can be saved.

The state government has given strict instructions to make sure that Covid patients get all the medicines on an immediate basis.

(This story has been published from a wire agency feed without modifications to the text. Only the headline has been changed.)

Get Swarajya in your inbox everyday. Subscribe here.

An Appeal...

Dear Reader,

As you are no doubt aware, Swarajya is a media product that is directly dependent on support from its readers in the form of subscriptions. We do not have the muscle and backing of a large media conglomerate nor are we playing for the large advertisement sweep-stake.

Our business model is you and your subscription. And in challenging times like these, we need your support now more than ever.

We deliver over 10 - 15 high quality articles with expert insights and views. From 7AM in the morning to 10PM late night we operate to ensure you, the reader, get to see what is just right.

Becoming a Patron or a subscriber for as little as Rs 1200/year is the best way you can support our efforts.

Become A Patron
Become A Subscriber
Comments
Get Swarajya in your inbox everyday. Subscribe here.
Advertisement

Latest Articles

    Artboard 4Created with Sketch.